The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
RobergeR.J.Dextromethorphan-and pseudoephedrine-induced agitated psychosis and ataxia: Case report. J Emerg Med.1999; 17: 285–8.
2.
ZahnK.A., LiR.L., PurssellR.A.Cardiovascular toxicity after ingestion of “herbal ecstacy.”J Emerg Med.1999; 17: 289–91.
